MTHFR ‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review)
International Journal of Molecular Medicine · 2026
DOI: 10.3892/ijmm.2026.5741 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2026. Verfasst von Pablo Michael Navarro-Rodríguez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Genomics, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Autoimmune Diseases, Epigenesis, Genetic, Folic Acid. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
The one‑carbon metabolism pathway, regulated by the methylenetetrahydrofolate reductase (MTHFR) enzyme, represents a key nexus where genetic predisposition and nutrient status converge to shape the epigenetic landscape of autoimmune diseases. The objective of the present review is to synthesize evidence of how the MTHFR‑folate axis drives epigenomic patterns in these conditions. One of the main diseases involved is rheumatoid arthritis, where drug‑naïve patients show T‑cell and synovial hypomethylation with cytokine‑driven DNMT suppression, a process aggravated by reduced folate availability and MTHFR polymorphisms that constrain S‑adenosylmethionine supply. Similarly, in systemic lupus erythematosus, CD4+ T cells exhibit global hypomethylation with an interferon‑skewed signature (such as IFI44L), associated with impaired MTHFR activity and a folate‑dependent SAM:SAH imbalance that further diminishes DNMT function. Finally, in celiac disease, intestinal differential methylation, including LINE‑1 hypomethylation, is observed, driven by gluten‑induced villous atrophy and folate malabsorption. Overall, impaired one‑carbon metabolism and MTHFR‑dependent methylation capacity may be key determinants of epigenomic dysfunction underlying autoimmune disease and its clinical severity.17.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Biology and Genomics, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico.
- Department of Clinical Medicine, Institute of Research in Biomedical Sciences, University Center of Health Sciences, University of Guadalajara, Guadalajara, Jalisco 44340, Mexico.
Zitieren
APA
Navarro-Rodríguez, P. M., Bajeca-Serrano, R. F., Turrubiates-Hernández, F. J., Ceja-Gálvez, H. R., Hernández-Bello, J., Hernández-Ramírez, C. O., Ramírez-de Los Santos, S., & Muñoz-Valle, J. F. (2026). MTHFR ‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2026.5741
Vancouver
Navarro-Rodríguez PM, Bajeca-Serrano RF, Turrubiates-Hernández FJ, Ceja-Gálvez HR, Hernández-Bello J, Hernández-Ramírez CO, et al. MTHFR ‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review). International Journal of Molecular Medicine. 2026. doi:10.3892/ijmm.2026.5741
BibTeX
@article{NavarroRodrguez2026,
author = {Navarro-Rodríguez, Pablo Michael and Bajeca-Serrano, Ramón Francisco and Turrubiates-Hernández, Francisco Javier and Ceja-Gálvez, Hazael Ramiro and Hernández-Bello, Jorge and Hernández-Ramírez, Cristian Oswaldo and Ramírez-de Los Santos, Saúl and Muñoz-Valle, José Francisco},
title = {MTHFR ‑folate axis as a modulator of the epigenetic landscape in autoimmune diseases (Review)},
journal = {International Journal of Molecular Medicine},
year = {2026},
doi = {10.3892/ijmm.2026.5741}
}
EUVIMED